Advertisement

Dry Eye Syndrome Preferred Practice Pattern®

Published:October 23, 2018DOI:https://doi.org/10.1016/j.ophtha.2018.10.023
      AMERICAN ACADEMY™ OF OPHTHALMOLOGY
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Scottish Intercollegiate Guidelines Network (SIGN)
        SIGN 50: a guideline developer's handbook.
        SIGN, Edinburgh2015 (SIGN publication no. 50). [November 2015].
        • Guyatt GH
        • Oxman AD
        • Vist GE
        • et al.
        GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
        BMJ. 2008; 336: 924-926
        • GRADE Working Group
        Organizations that have endorsed or that are using GRADE.
        http://www.gradeworkinggroup.org/
        Date accessed: June 19, 2018
        • The Dry Eye Assessment and Management Study Research Group
        n–3 Fatty acid supplementation for the treatment of dry eye disease.
        N Engl J Med. 2018; 378: 1681-1690
        • Straub M
        • Bron AM
        • Muselier-Mathieu A
        • Creuzot-Garcher C
        Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up.
        Br J Ophthalmol. 2016; 100: 1547-1550
        • Wilson SE
        • Perry HD
        Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
        Ophthalmology. 2007; 114: 76-79
        • Sheppard JD
        • Torkildsen GL
        • Lonsdale JD
        • et al.
        Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
        Ophthalmology. 2014; 121: 475-483
        • Holland EJ
        • Luchs J
        • Karpecki PM
        • et al.
        Lifitegrast for the treatment of dry eye disease: results of a phase III, randomized, double-masked, placebo-controlled trial (OPUS-3).
        Ophthalmology. 2017; 124: 53-60
        • Tauber J
        • Karpecki P
        • Latkany R
        • OPUS-2 Investigators
        • et al.
        Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 study.
        Ophthalmology. 2015; 122: 2423-2431
        • Donnenfeld ED
        • Karpecki PM
        • Majmudar PA
        • et al.
        Safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease: a 1-year, multicenter, randomized, placebo-controlled study.
        Cornea. 2016; 35: 741-748
        • Woodward MA
        • Randleman JB
        • Stulting RD
        Dissatisfaction after multifocal intraocular lens implantation.
        J Cataract Refract Surg. 2009; 35: 992-997
        • Iglesias E
        • Sajnani R
        • Levitt RC
        • Sarantopoulos CD
        • Galor A
        Epidemiology of Persistent Dry Eye-Like Symptoms After Cataract Surgery.
        Cornea. 2018; 37: 893-898
        • Choi YJ
        • Park SY
        • Jun I
        • et al.
        Perioperative Ocular Parameters Associated With Persistent Dry Eye Symptoms After Cataract Surgery.
        Cornea. 2018; 37: 734-739
        • Zintzaras E
        • Voulgarelis M
        • Moutsopoulos HM
        The risk of lymphoma development in autoimmune diseases: a meta-analysis.
        Arch Intern Med. 2005; 165: 2337-2344
        • Schein OD
        • Munoz B
        • Tielsch JM
        • Bandeen-Roche K
        • West S
        Prevalence of dry eye among the elderly.
        Am J Ophthalmol. 1997; 124: 723-728
      1. Karakus SM, P.; Agrawal, D; Heinrich, C.; Ramulu, PY; Akpek, EH. Impact of Dry Eye on Prolonged Reading. Optometry and Vision Science. In Press.

        • Mathews PM
        • Ramulu PY
        • Swenor BS
        • Utine CA
        • Rubin GS
        • Akpek EK
        Functional impairment of reading in patients with dry eye.
        Br J Ophthalmol. 2017; 101: 481-486
        • Sun MJ
        • Rubin GS
        • Akpek EK
        • Ramulu PY
        Impact of Glaucoma and Dry Eye on Text-Based Searching.
        Transl Vis Sci Technol. 2017; 6: 24
        • van Landingham SW
        • West SK
        • Akpek EK
        • Munoz B
        • Ramulu PY
        Impact of dry eye on reading in a population-based sample of the elderly: the Salisbury Eye Evaluation.
        Br J Ophthalmol. 2014; 98: 639-644
        • Hikichi T
        • Yoshida A
        • Fukui Y
        • et al.
        Prevalence of dry eye in Japanese eye centers.
        Graefes Arch Clin Exp Ophthalmol. 1995; 233: 555-558
        • McCarty CA
        • Bansal AK
        • Livingston PM
        • Stanislavsky YL
        • Taylor HR
        The epidemiology of dry eye in Melbourne, Australia.
        Ophthalmology. 1998; 105: 1114-1119
        • Moss SE
        • Klein R
        • Klein BE
        Prevalence of and risk factors for dry eye syndrome.
        Arch Ophthalmol. 2000; 118: 1264-1268
        • Schaumberg DA
        • Dana R
        • Buring JE
        • Sullivan DA
        Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies.
        Arch Ophthalmol. 2009; 127: 763-768
        • Schaumberg DA
        • Sullivan DA
        • Buring JE
        • Dana MR
        Prevalence of dry eye syndrome among US women.
        Am J Ophthalmol. 2003; 136: 318-326
        • Lemp MA
        • Crews LA
        • Bron AJ
        • Foulks GN
        • Sullivan BD
        Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study.
        Cornea. 2012; 31: 472-478
        • Yazdani C
        • McLaughlin T
        • Smeeding JE
        • Walt J
        Prevalence of treated dry eye disease in a managed care population.
        Clin Ther. 2001; 23: 1672-1682
        • Viso E
        • Rodriguez-Ares MT
        • Gude F
        Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study).
        Ophthalmic Epidemiol. 2009; 16: 15-21
        • Xu L
        • You QS
        • Wang YX
        • Jonas JB
        Associations between gender, ccular parameters and diseases: The Beijing Eye Study.
        Ophthalmic Res. 2010; 45: 197-203
        • Moss SE
        • Klein R
        • Klein BE
        Long-term incidence of dry eye in an older population.
        Optom Vis Sci. 2008; 85: 668-674
        • Uchino M
        • Schaumberg DA
        • Dogru M
        • et al.
        Prevalence of dry eye disease among Japanese visual display terminal users.
        Ophthalmology. 2008; 115: 1982-1988
        • Leung EW
        • Medeiros FA
        • Weinreb RN
        Prevalence of ocular surface disease in glaucoma patients.
        J Glaucoma. 2008; 17: 350-355
        • Rossi GC
        • Tinelli C
        • Pasinetti GM
        • Milano G
        • Bianchi PE
        Dry eye syndrome-related quality of life in glaucoma patients.
        Eur J Ophthalmol. 2009; 19: 572-579
        • Schaumberg DA
        • Buring JE
        • Sullivan DA
        • Dana MR
        Hormone replacement therapy and dry eye syndrome.
        JAMA. 2001; 286: 2114-2119
        • Ababneh OH
        • Cetinkaya A
        • Kulwin DR
        Long-term efficacy and safety of botulinum toxin a injections to treat blepharospasm and hemifacial spasm.
        Clin Experiment Ophthalmol. 2014; : 254-261
        • Ozgur OK
        • Murariu D
        • Parsa AA
        • Parsa FD
        Dry eye syndrome due to botulinum toxin type-A injection: guideline for prevention.
        Hawaii J Med Public Health. 2012; 71: 120-123
        • Manfredi M
        • Scoditti U
        • Angelini M
        • et al.
        Dry mouth as an initial sign of food-borne botulism: a case report and review of the literature.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 111: e15-18
        • Zou X
        • Lu L
        • Xu Y
        • et al.
        Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: the Beixinjing eye study.
        BMC Ophthalmol. 2018; 18: 117
        • Stern ME
        • Beuerman RW
        • Fox RI
        • Gao J
        • Mircheff AK
        • Pflugfelder SC
        The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.
        Cornea. 1998; 17: 584-589
        • Bacman S
        • Berra A
        • Sterin-Borda L
        • Borda E
        Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome.
        Invest Ophthalmol Vis Sci. 2001; 42: 321-327
        • Solomon A
        • Dursun D
        • Liu Z
        • Xie Y
        • Macri A
        • Pflugfelder SC
        Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
        Invest Ophthalmol Vis Sci. 2001; 42: 2283-2292
        • Kunert KS
        • Tisdale AS
        • Stern ME
        • Smith JA
        • Gipson IK
        Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes.
        Arch Ophthalmol. 2000; 118: 1489-1496
        • Pflugfelder SC
        • Solomon A
        • Stern ME
        The diagnosis and management of dry eye: a twenty-five-year review.
        Cornea. 2000; 19: 644-649
        • Pflugfelder SC
        Antiinflammatory therapy for dry eye.
        Am J Ophthalmol. 2004; 137: 337-342
        • Seedor JA
        • Lamberts D
        • Bergmann RB
        • Perry HD
        Filamentary keratitis associated with diphenhydramine hydrochloride (Benadryl).
        Am J Ophthalmol. 1986; 101: 376-377
        • Mader TH
        • Stulting RD
        Keratoconjunctivitis sicca caused by diphenoxylate hydrochloride with atropine sulfate (Lomotil).
        Am J Ophthalmol. 1991; 111: 377-378
        • Bergmann MT
        • Newman BL
        • Johnson Jr., NC
        The effect of a diuretic (hydrochlorothiazide) on tear production in humans.
        Am J Ophthalmol. 1985; 99: 473-475
        • Cumurcu T
        • Sezer E
        • Kilic R
        • Bulut Y
        Comparison of dose-related ocular side effects during systemic isotretinoin administration.
        Eur J Ophthalmol. 2009; 19: 196-200
        • Browning DJ
        • Rosenwasser G
        • Lugo M
        Ocular rosacea in blacks.
        Am J Ophthalmol. 1986; 101: 441-444
        • Kellen R
        • Silverberg NB
        Pediatric rosacea.
        Cutis. 2016; 98: 49-53
        • American Academy of Ophthalmology Cornea/External Disease Panel
        Preferred Practice Pattern® Guidelines. Blepharitis.
        American Academy of Ophthalmology, San Francisco, CA2018
        • Berg M
        • Liden S
        An epidemiological study of rosacea.
        Acta Derm Venereol. 1989; 69: 419-423
        • Chalmers DA
        Rosacea: recognition and management for the primary care provider.
        Nurse Pract. 1997; 22 (23-18, 30.): 18
        • Viswalingam M
        • Rauz S
        • Morlet N
        • Dart JK
        Blepharokeratoconjunctivitis in children: diagnosis and treatment.
        Br J Ophthalmol. 2005; 89: 400-403
        • Cetinkaya A
        • Akova YA
        Pediatric ocular acne rosacea: long-term treatment with systemic antibiotics.
        Am J Ophthalmol. 2006; 142: 816-821
        • Donaldson KE
        • Karp CL
        • Dunbar MT
        Evaluation and treatment of children with ocular rosacea.
        Cornea. 2007; 26: 42-46
        • Bamford JT
        • Gessert CE
        • Renier CM
        • et al.
        Childhood stye and adult rosacea.
        J Am Acad Dermatol. 2006; 55: 951-955
        • Akpek EK
        • Klimava A
        • Thorne JE
        • Martin D
        • Lekhanont K
        • Ostrovsky A
        Evaluation of patients with dry eye for presence of underlying Sjogren syndrome.
        Cornea. 2009; 28: 493-497
        • Liew MS
        • Zhang M
        • Kim E
        • Akpek EK
        Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye.
        Br J Ophthalmol. 2012; 96: 1498-1503
        • Voulgarelis M
        • Skopouli FN
        Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.
        Clin Rev Allergy Immunol. 2007; 32: 265-274
        • Tzioufas AG
        • Voulgarelis M
        Update on Sjogren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
        Best Pract Res Clin Rheumatol. 2007; 21: 989-1010
        • James DG
        Ocular Sarcoidosis.
        Br J Ophthalmol. 1964; 48: 461-470
        • Drosos AA
        • Constantopoulos SH
        • Psychos D
        • Stefanou D
        • Papadimitriou CS
        • Moutsopoulos HM
        The forgotten cause of sicca complex; sarcoidosis.
        J Rheumatol. 1989; 16: 1548-1551
        • Fox RI
        Systemic diseases associated with dry eye.
        Int Ophthalmol Clin. 1994; 34: 71-87
        • Merayo-Lloves J
        • Baltatzis S
        • Foster CS
        Epstein-Barr virus dacryoadenitis resulting in keratoconjunctivitis sicca in a child.
        Am J Ophthalmol. 2001; 132: 922-923
        • Itescu S
        Diffuse infiltrative lymphocytosis syndrome in human immunodeficiency virus infection–a Sjogren's-like disease.
        Rheum Dis Clin North Am. 1991; 17: 99-115
        • Lucca JA
        • Farris RL
        • Bielory L
        • Caputo AR
        Keratoconjunctivitis sicca in male patients infected with human immunodeficiency virus type 1.
        Ophthalmology. 1990; 97: 1008-1010
        • Abe T
        • Nakajima A
        • Matsunaga M
        • Sakuragi S
        • Komatsu M
        Decreased tear lactoferrin concentration in patients with chronic hepatitis C.
        Br J Ophthalmol. 1999; 83: 684-687
        • Siagris D
        • Pharmakakis N
        • Christofidou M
        • et al.
        Keratoconjunctivitis sicca and chronic HCV infection.
        Infection. 2002; 30: 229-233
        • Pflugfelder SC
        • Roussel TJ
        • Culbertson WW
        Primary Sjogren's syndrome after infectious mononucleosis.
        JAMA. 1987; 257: 1049-1050
        • Whittingham S
        • McNeilage J
        • Mackay IR
        Primary Sjogren's syndrome after infectious mononucleosis.
        Ann Intern Med. 1985; 102: 490-493
        • Pflugfelder SC
        • Crouse CA
        • Monroy D
        • Yen M
        • Rowe M
        • Atherton SS
        Epstein-Barr virus and the lacrimal gland pathology of Sjogren's syndrome.
        Am J Pathol. 1993; 143: 49-64
        • Ogawa Y
        • Okamoto S
        • Wakui M
        • et al.
        Dry eye after haematopoietic stem cell transplantation.
        Br J Ophthalmol. 1999; 83: 1125-1130
        • Fahnehjelm KT
        • Tornquist AL
        • Winiarski J
        Dry-eye syndrome after allogeneic stem-cell transplantation in children.
        Acta Ophthalmol. 2008; 86: 253-258
        • Ogawa Y
        • Kuwana M
        Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation.
        Cornea. 2003; 22: S19-27
        • Auw-Haedrich C
        • Potsch C
        • Bohringer D
        • et al.
        Histological and immunohistochemical characterisation of conjunctival graft vs host disease following haematopoietic stem cell transplantation.
        Graefes Arch Clin Exp Ophthalmol. 2007; 245: 1001-1007
        • Deuschl G
        • Goddemeier C
        Spontaneous and reflex activity of facial muscles in dystonia, Parkinson's disease, and in normal subjects.
        J Neurol Neurosurg Psychiatry. 1998; 64: 320-324
        • Wang MTM
        • Tien L
        • Han A
        • et al.
        Impact of blinking on ocular surface and tear film parameters.
        Ocul Surf. 2018;
        • Moon JH
        • Kim KW
        • Moon NJ
        Smartphone use is a risk factor for pediatric dry eye disease according to region and age: a case control study.
        BMC Ophthalmol. 2016; 16: 188
        • Lemp MA
        Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.
        CLAO J. 1995; 21: 221-232
        • American Academy of Ophthalmology Basic and Clinical Science Course Subcommittee
        Basic and Clinical Science Course. External Disease and Cornea: Section 8, 2017-2018.
        American Academy of Ophthalmology, San Francisco, CA2017: 55-56
        • Craig JP
        • Nelson JD
        • Azar DT
        • et al.
        TFOS DEWS II Report executive summary.
        Ocul Surf. 2017; 15: 802-812
        • Wolffsohn JS
        • Arita R
        • Chalmers R
        • et al.
        TFOS DEWS II Diagnostic methodology report.
        Ocul Surf. 2017; 15: 539-574
        • Feder RS
        • Olsen TW
        • Prum Jr., BE
        • et al.
        Comprehensive adult medical eye evaluation Preferred Practice Pattern® guidelines.
        Ophthalmology. 2016; 123 (or): P209-236
        • Karakus S
        • Baer AN
        • Agrawal D
        • Gurakar M
        • Massof RW
        • Akpek EK
        Utility of novel autoantibodies in the diagnosis of Sj□gren's syndrome among patients with dry eye.
        Cornea. 2018; 37: 405-411
        • Keech A
        • Senchyna M
        • Jones L
        Impact of time between collection and collection method on human tear fluid osmolarity.
        Curr Eye Res. 2013; 38: 428-436
        • Lemp MA
        • Bron AJ
        • Baudouin C
        • et al.
        Tear osmolarity in the diagnosis and management of dry eye disease.
        Am J Ophthalmol. 2011; 151: 792-798
        • Sullivan BD
        • Whitmer D
        • Nichols KK
        • et al.
        An objective approach to dry eye disease severity.
        Invest Ophthalmol Vis Sci. 2010; 51: 6125-6130
        • Massof RW
        • McDonnell PJ
        Latent dry eye disease state variable.
        Invest Ophthalmol Vis Sci. 2012; 53: 1905-1916
        • Messmer EM
        • Bulgen M
        • Kampik A
        Hyperosmolarity of the tear film in dry eye syndrome.
        Dev Ophthalmol. 2010; 45: 129-138
        • Sambursky R
        • Davitt 3rd, WF
        • Friedberg M
        • Tauber S
        Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease.
        Cornea. 2014; 33: 812-818
        • American Academy of Ophthalmology Cornea/External Disease Panel
        Preferred Practice Pattern® Guidelines. Conjunctivitis.
        American Academy of Ophthalmology, San Francisco, CA2018
        • Pflugfelder SC
        • Tseng SC
        • Sanabria O
        • et al.
        Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation.
        Cornea. 1998; 17: 38-56
        • Heigle TJ
        • Pflugfelder SC
        Aqueous tear production in patients with neurotrophic keratitis.
        Cornea. 1996; 15: 135-138
        • Tanenbaum M
        • McCord Jr, CD
        Lacrimal drainage system.
        in: Tasman W Jaeger EA Duane's Ophthalmology. 15th ed. Lippincott Williams & Wilkins, Philadelphia, PA2009 (chapter 13.)
        • Lemp MA
        • Foulks GN
        Diagnosis and management of dry eye disease.
        in: Tasman W Jaeger EA Duane's Ophthalmology. 15th ed. Lippincott Williams & Wilkins, Philadelphia, PA2009 (chapter 14.)
        • Macri A
        • Rolando M
        • Pflugfelder S
        A standardized visual scale for evaluation of tear fluorescein clearance.
        Ophthalmology. 2000; 107: 1338-1343
        • Begley CG
        • Chalmers RL
        • Abetz L
        • et al.
        The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity.
        Invest Ophthalmol Vis Sci. 2003; 44: 4753-4761
        • Schein OD
        • Tielsch JM
        • Munoz B
        • Bandeen-Roche K
        • West S
        Relation between signs and symptoms of dry eye in the elderly. A population-based perspective.
        Ophthalmology. 1997; 104: 1395-1401
        • Chalmers RL
        • Begley CG
        Dryness symptoms among an unselected clinical population with and without contact lens wear.
        Cont Lens Anterior Eye. 2006; 29: 25-30
        • Chalmers RL
        • Begley CG
        • Moody K
        • Hickson-Curran SB
        Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) and opinion of contact lens performance.
        Optom Vis Sci. 2012; 89: 1435-1442
        • Goren MB
        • Goren SB
        Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca.
        Am J Ophthalmol. 1988; 106: 570-574
        • Clinch TE
        • Benedetto DA
        • Felberg NT
        • Laibson PR
        Schirmer's test. A closer look.
        Arch Ophthalmol. 1983; 101: 1383-1386
        • Altinors DD
        • Akca S
        • Akova YA
        • et al.
        Smoking associated with damage to the lipid layer of the ocular surface.
        Am J Ophthalmol. 2006; 141: 1016-1021
        • Grus FH
        • Sabuncuo P
        • Augustin A
        • Pfeiffer N
        Effect of smoking on tear proteins.
        Graefes Arch Clin Exp Ophthalmol. 2002; 240: 889-892
        • Tsubota K
        • Nakamori K
        Effects of ocular surface area and blink rate on tear dynamics.
        Arch Ophthalmol. 1995; 113: 155-158
        • Pucker AD
        • Ng SM
        • Nichols JJ
        Over the counter (OTC) artificial tear drops for dry eye syndrome.
        Cochrane Database Syst Rev. 2016; 2CD009729
        • Terry MA
        • Ousley PJ
        Deep lamellar endothelial keratoplasty in the first United States patients: early clinical results.
        Cornea. 2001; 20: 239-243
        • U.S. Food and Drug Administration, Center for Drug Evaluation and Research
        Restasis™ (cyclosporine ophthalmic emulsion) 0.05% sterile, preservative-free. NDA 50-790/S-001. 2003:6.
        • Roberts CW
        • Carniglia PE
        • Brazzo BG
        Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye.
        Cornea. 2007; 26: 805-809
        • Perry HD
        • Solomon R
        • Donnenfeld ED
        • et al.
        Evaluation of topical cyclosporine for the treatment of dry eye disease.
        Arch Ophthalmol. 2008; 126: 1046-1050
        • Su MY
        • Perry HD
        • Barsam A
        • et al.
        The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.
        Cornea. 2011; 30: 1098-1104
        • Stern ME
        • Gao J
        • Schwalb TA
        • et al.
        Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye.
        Invest Ophthalmol Vis Sci. 2002; 43: 2609-2614
        • Pflugfelder SC
        • Maskin SL
        • Anderson B
        • et al.
        A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
        Am J Ophthalmol. 2004; 138: 444-457
        • Marsh P
        • Pflugfelder SC
        Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome.
        Ophthalmology. 1999; 106: 811-816
        • Prabhasawat P
        • Tseng SC
        Frequent association of delayed tear clearance in ocular irritation.
        Br J Ophthalmol. 1998; 82: 666-675
        • Sainz De La Maza Serra M
        • Simon Castellvi C
        • Kabbani O
        Nonpreserved topical steroids and lacrimal punctal occlusion for severe keratoconjunctivitis sicca [in Spanish].
        Arch Soc Esp Oftalmol. 2000; 75: 751-756
        • Wojtowicz JC
        • Butovich I
        • Uchiyama E
        • Aronowicz J
        • Agee S
        • McCulley JP
        Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye.
        Cornea. 2011; 30: 308-314
        • Jackson MA
        • Burrell K
        • Gaddie IB
        • Richardson SD
        Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A.
        Clin Ophthalmol. 2011; 5: 1201-1206
        • Perez VL
        • Pflugfelder SC
        • Zhang S
        • Shojaei A
        • Haque R
        Lifitegrast, a novel integrin antagonist for treatment of dry eye disease.
        Ocul Surf. 2016; 14: 207-215
        • Lee SY
        • Tong L
        Lipid-containing lubricants for dry eye: a systematic review.
        Optom Vis Sci. 2012; 89: 1654-1661
        • Macsai MS
        The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis).
        Trans Am Ophthalmol Soc. 2008; 106: 336-356
        • Ervin AM
        • Wojciechowski R
        • Schein O
        Punctal occlusion for dry eye syndrome.
        Cochrane Database Syst Rev. 2010; CD006775
        • Chen F
        • Wang J
        • Chen W
        • Shen M
        • Xu S
        • Lu F
        Upper punctal occlusion versus lower punctal occlusion in dry eye.
        Invest Ophthalmol Vis Sci. 2010; 51: 5571-5577
        • Altan-Yaycioglu R
        • Gencoglu EA
        • Akova YA
        • Dursun D
        • Cengiz F
        • Akman A
        Silicone versus collagen plugs for treating dry eye: results of a prospective randomized trial including lacrimal scintigraphy.
        Am J Ophthalmol. 2005; 140: 88-93
        • Nava-Castaneda A
        • Tovilla-Canales JL
        • Rodriguez L
        • Tovilla YPJL
        • Jones CE
        Effects of lacrimal occlusion with collagen and silicone plugs on patients with conjunctivitis associated with dry eye.
        Cornea. 2003; 22: 10-14
        • Tai MC
        • Cosar CB
        • Cohen EJ
        • Rapuano CJ
        • Laibson PR
        The clinical efficacy of silicone punctal plug therapy.
        Cornea. 2002; 21: 135-139
        • Horwath-Winter J
        • Thaci A
        • Gruber A
        • Boldin I
        Long-term retention rates and complications of silicone punctal plugs in dry eye.
        Am J Ophthalmol. 2007; 144: 441-444
        • Mazow ML
        • McCall T
        • Prager TC
        Lodged intracanalicular plugs as a cause of lacrimal obstruction.
        Ophthal Plast Reconstr Surg. 2007; 23: 138-142
        • SmartPlug Study Group
        Management of complications after insertion of the SmartPlug punctal plug: a study of 28 patients.
        Ophthalmology. 2006; 1131859
        • Feder RS
        • Rao RR
        • Lissner GS
        • Bryar PJ
        • Szatkowski M
        Atypical mycobacterial keratitis and canaliculitis in a patient with an indwelling SmartPLUG.
        Br J Ophthalmol. 2010; 94: 383-384
        • Koffler BH
        • McDonald M
        • Nelinson DS
        Improved signs, symptoms, and quality of life associated with dry eye syndrome: hydroxypropyl cellulose ophthalmic insert patient registry.
        Eye Contact Lens. 2010; 36: 170-176
        • Luchs JI
        • Nelinson DS
        • Macy JI
        Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry.
        Cornea. 2010; 29: 1417-1427
        • Gumus K
        • Pflugfelder SC
        Intranasal tear neurostimulation: an emerging concept in the treatment of dry eye.
        Int Ophthalmol Clin. 2017; 57: 101-108
        • Geerling G
        • Raus P
        • Murube J
        Minor salivary gland transplantation.
        Dev Ophthalmol. 2008; 41: 243-254
        • Vivino FB
        • Al-Hashimi I
        • Khan Z
        • et al.
        Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group.
        Arch Intern Med. 1999; 159: 174-181
        • Fox RI
        • Konttinen Y
        • Fisher A
        Use of muscarinic agonists in the treatment of Sjogren's syndrome.
        Clin Immunol. 2001; 101: 249-263
        • Petrone D
        • Condemi JJ
        • Fife R
        • Gluck O
        • Cohen S
        • Dalgin P
        A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
        Arthritis Rheum. 2002; 46: 748-754
        • Nelson JD
        • Friedlaender M
        • Yeatts RP
        • et al.
        Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjogren's syndrome. The MGI PHARMA Sjogren's Syndrome Study Group.
        Adv Exp Med Biol. 1998; 438: 979-983
        • Tsubota K
        • Goto E
        • Fujita H
        • et al.
        Treatment of dry eye by autologous serum application in Sjogren's syndrome.
        Br J Ophthalmol. 1999; 83: 390-395
        • Chiang CC
        • Lin JM
        • Chen WL
        • Tsai YY
        Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
        Cornea. 2007; 26: 861-863
        • Pan Q
        • Angelina A
        • Marrone M
        • Stark WJ
        • Akpek EK
        Autologous serum eye drops for dry eye.
        Cochrane Database Syst Rev. 2017; 2CD009327
        • Espinosa A
        • Hjorth-Hansen H
        • Aasly K
        • Teigum I
        • Sivertsen G
        • Seghatchian J
        Implementation of a standardised method for the production of allogeneic serum eye drops from regular blood donors in a Norwegian University Hospital: Some methodological aspects and clinical considerations.
        Transfus Apher Sci. 2015; 53: 88-91
        • Na KS
        • Kim MS
        Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.
        J Ocul Pharmacol Ther. 2012; 28: 479-483
        • Cosar CB
        • Cohen EJ
        • Rapuano CJ
        • et al.
        Tarsorrhaphy: clinical experience from a cornea practice.
        Cornea. 2001; 20: 787-791
        • Gould HL
        The dry eye and scleral contact lenses.
        Am J Ophthalmol. 1970; 70: 37-41
        • Krejci L
        Scleral gel contact lenses in treatment of dry eyes.
        Br J Ophthalmol. 1972; 56: 425-428
        • Alipour F
        • Kheirkhah A
        • Jabarvand Behrouz M
        Use of mini scleral contact lenses in moderate to severe dry eye.
        Cont Lens Anterior Eye. 2012; 35: 272-276
        • Jacobs DS
        • Rosenthal P
        Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease.
        Cornea. 2007; 26: 1195-1199
        • Nettune GR
        • Pflugfelder SC
        Post-LASIK tear dysfunction and dysesthesia.
        Ocul Surf. 2010; 8: 135-145
        • Naumann GO
        • Schlotzer-Schrehardt U
        Amantadine-associated corneal edema.
        Ophthalmology. 2009; 116 (author reply 1231.): 1230-1231
        • Chuck RS
        • Jacobs DS
        • Lee JK
        • et al.
        Refractive errors & refractive surgery Preferred Practice Pattern®.
        Ophthalmology. 2018; 125 (or): P1-P104
        • Shimmura S
        • Shimazaki J
        • Tsubota K
        Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye.
        Cornea. 1999; 18: 408-411
        • Lee JT
        • Teale CW
        Development of an economic model to assess costs and outcomes associated with dry eye disease.
        Pharmacotherapy. 2000; 20 (Presented at the 2000 Spring Practice and Research Forum of the American College of Clinical Pharmacy; April 2-5, 2000; Monterey, CA.): 356
        • Miljanovic B
        • Dana R
        • Sullivan DA
        • Schaumberg DA
        Impact of dry eye syndrome on vision-related quality of life.
        Am J Ophthalmol. 2007; 143: 409-415
        • Mertzanis P
        • Abetz L
        • Rajagopalan K
        • et al.
        The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.
        Invest Ophthalmol Vis Sci. 2005; 46: 46-50
        • Schiffman RM
        • Walt JG
        • Jacobsen G
        • Doyle JJ
        • Lebovics G
        • Sumner W
        Utility assessment among patients with dry eye disease.
        Ophthalmology. 2003; 110: 1412-1419
        • Li M
        • Gong L
        • Sun X
        • Chapin WJ
        Anxiety and depression in patients with dry eye syndrome.
        Curr Eye Res. 2011; 36: 1-7
        • Galor A
        • Feuer W
        • Lee DJ
        • et al.
        Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database.
        Am J Ophthalmol. 2012; 154: 340-346
        • Kim KW
        • Han SB
        • Han ER
        • et al.
        Association between depression and dry eye disease in an elderly population.
        Invest Ophthalmol Vis Sci. 2011; 52: 7954-7958
        • Ware JE
        SF-36 Health Survey: Manual and Interpretation Guide.
        The Health Institute, Boston, MA1993
        • Hirsch JD
        Considerations in the pharmacoeconomics of dry eye.
        Manag Care. 2003; 12: 33-38
        • Reddy P
        • Grad O
        • Rajagopalan K
        The economic burden of dry eye: a conceptual framework and preliminary assessment.
        Cornea. 2004; 23: 751-761
        • Kozma CM
        • Hirsch JD
        • Wojcik AR
        Economic and quality of life impact of dry eye symptoms.
        Invest Ophthalmol Vis Sci. 2000; 41: S928
        • Wojcik AR
        • Walt JG
        Patient-reported outcomes of dry eye symptoms from a Sjogren's syndrome patient survey.
        Invest Ophthalmol Vis Sci. 2002; 43 (E-Abstract 59.)
        • Hirsch JD
        • Kozma CM
        • Wojcik AR
        • Reis B
        Economic and quality-of-life impact of dry eye symptoms: a Sjögren's syndrome patient survey.
        Invest Ophthalmol Vis Sci. 1998; 39: S65
        • Nelson JD
        • Helms H
        • Fiscella R
        • Southwell Y
        • Hirsch JD
        A new look at dry eye disease and its treatment.
        Adv Ther. 2000; 17: 84-93
        • Yu J
        • Asche CV
        • Fairchild CJ
        The economic burden of dry eye disease in the United States: a decision tree analysis.
        Cornea. 2011; 30: 379-387
      2. The management of dry eye.
        Drug Ther Bull. 2016; 54: 9-12
        • Jara LJ
        • Navarro C
        • Brito-Zeron Mdel P
        • Garcia-Carrasco M
        • Escarcega RO
        • Ramos-Casals M
        Thyroid disease in Sjogren's syndrome.
        Clin Rheumatol. 2007; 26: 1601-1606
        • Manthorpe R
        • Jacobsson LT
        • Kirtava Z
        • Theander E
        Epidemiology of Sjogren's syndrome, especially its primary form.
        Ann Med Interne (Paris). 1998; 149: 7-11
        • Alamanos Y
        • Tsifetaki N
        • Voulgari PV
        • Venetsanopoulou AI
        • Siozos C
        • Drosos AA
        Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003.
        Rheumatology (Oxford). 2006; 45: 187-191
        • Pillemer SR
        • Matteson EL
        • Jacobsson LT
        • et al.
        Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota.
        Mayo Clin Proc. 2001; 76: 593-599
        • Thomas E
        • Hay EM
        • Hajeer A
        • Silman AJ
        Sjogren's syndrome: a community-based study of prevalence and impact.
        Br J Rheumatol. 1998; 37: 1069-1076
        • Plesivcnik Novljan M
        • Rozman B
        • Hocevar A
        • Grmek M
        • Kveder T
        • Tomsic M
        Incidence of primary Sjogren's syndrome in Slovenia.
        Ann Rheum Dis. 2004; 63: 874-876
        • Ioannidis JP
        • Vassiliou VA
        • Moutsopoulos HM
        Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome.
        Arthritis Rheum. 2002; 46: 741-747
        • Theander E
        • Manthorpe R
        • Jacobsson LT
        Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study.
        Arthritis Rheum. 2004; 50: 1262-1269
        • Shiboski CH
        • Shiboski SC
        • Seror R
        • International Sjögren's Syndrome Criteria Working Group
        • et al.
        2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data-driven methodology involving three international patient cohorts.
        Arthritis Rheumatol. 2017; 69: 35-45
        • Shiboski CH
        • Shiboski SC
        • Seror R
        • International Sjögren's Syndrome Criteria Working Group
        • et al.
        2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.
        Ann Rheum Dis. 2017; 76: 9-16
        • Foulks GN
        • Forstot SL
        • Donshik PC
        • et al.
        Clinical guidelines for management of dry eye associated with Sjogren disease.
        Ocul Surf. 2015; 13: 118-132
        • Akpek EK
        • Lindsley KB
        • Adyanthaya RS
        • Swamy R
        • Baer AN
        • McDonnell PJ
        Treatment of Sjogren's syndrome-associated dry eye: an evidence-based review.
        Ophthalmology. 2011; 118: 1242-1252
        • Ramos-Casals M
        • Tzioufas AG
        • Stone JH
        • Siso A
        • Bosch X
        Treatment of primary Sjogren syndrome: a systematic review.
        JAMA. 2010; 304: 452-460
        • Feenstra RP
        • Tseng SC
        Comparison of fluorescein and rose bengal staining.
        Ophthalmology. 1992; 99: 605-617
        • Norn MS
        Lissamine green. Vital staining of cornea and conjunctiva.
        Acta Ophthalmol (Copenh). 1973; 51: 483-491
        • Manning FJ
        • Wehrly SR
        • Foulks GN
        Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal.
        Ophthalmology. 1995; 102: 1953-1957
        • Machado LM
        • Castro RS
        • Fontes BM
        Staining patterns in dry eye syndrome: rose bengal versus lissamine green.
        Cornea. 2009; 28: 732-734
        • Pflugfelder SC
        • Tseng SC
        • Yoshino K
        • Monroy D
        • Felix C
        • Reis BL
        Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation.
        Ophthalmology. 1997; 104: 223-235
        • Farris RL
        • Gilbard JP
        • Stuchell RN
        • Mandel ID
        Diagnostic tests in keratoconjunctivitis sicca.
        CLAO J. 1983; 9: 23-28
        • Lamberts DW
        • Foster CS
        • Perry HD
        Schirmer test after topical anesthesia and the tear meniscus height in normal eyes.
        Arch Ophthalmol. 1979; 97: 1082-1085
        • Xu KP
        • Yagi Y
        • Toda I
        • Tsubota K
        Tear function index. A new measure of dry eye.
        Arch Ophthalmol. 1995; 113: 84-88
        • Afonso AA
        • Monroy D
        • Stern ME
        • Feuer WJ
        • Tseng SC
        • Pflugfelder SC
        Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
        Ophthalmology. 1999; 106: 803-810
        • Macri A
        • Pflugfelder S
        Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease.
        Arch Ophthalmol. 2000; 118: 1632-1638
        • Farris RL
        • Stuchell RN
        • Mandel ID
        Basal and reflex human tear analysis. I. Physical measurements: osmolarity, basal volumes, and reflex flow rate.
        Ophthalmology. 1981; 88: 852-857
        • Gilbard JP
        • Farris RL
        Ocular surface drying and tear film osmolarity in thyroid eye disease.
        Acta Ophthalmol (Copenh). 1983; 61: 108-116
        • Farris RL
        • Stuchell RN
        • Mandel ID
        Tear osmolarity variation in the dry eye.
        Trans Am Ophthalmol Soc. 1986; 84: 250-268
        • Versura P
        • Profazio V
        • Campos EC
        Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases.
        Curr Eye Res. 2010; 35: 553-564
        • Tomlinson A
        • Khanal S
        • Ramaesh K
        • Diaper C
        • McFadyen A
        Tear film osmolarity: determination of a referent for dry eye diagnosis.
        Invest Ophthalmol Vis Sci. 2006; 47: 4309-4315
        • Jacobi C
        • Jacobi A
        • Kruse FE
        • Cursiefen C
        Tear film osmolarity measurements in dry eye disease using electrical impedance technology.
        Cornea. 2011; 30: 1289-1292
        • See CW
        • Bilonick RA
        • Feuer WJ
        • Galor A
        Comparison of two methods for composite score generation in dry eye syndrome.
        Invest Ophthalmol Vis Sci. 2013; 54: 6280-6286
        • Nelson JD
        • Farris RL
        Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca.
        Arch Ophthalmol. 1988; 106: 484-487
        • Larmo PS
        • Jarvinen RL
        • Setala NL
        • et al.
        Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye.
        J Nutr. 2010; 140: 1462-1468
        • Sullivan BD
        • Crews LA
        • Sonmez B
        • et al.
        Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management.
        Cornea. 2012; 31: 1000-1008
        • Bunya VY
        • Langelier N
        • Chen S
        • Pistilli M
        • Vivino FB
        • Massaro-Giordano G
        Tear osmolarity in Sjogren syndrome.
        Cornea. 2013; 32: 922-927
        • Mathews PM
        • Karakus S
        • Agrawal D
        • Hindman HB
        • Ramulu PY
        • Akpek EK
        Tear osmolarity and correlation with ocular surface parameters in patients with dry eye.
        Cornea. 2017; 36: 1352-1357